Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma. | Cancers (Basel) | 2022 | 35954384 | PubTator, text mining | PubMed |
| Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study. | Cancers (Basel) | 2022 | 35954356 | PubTator, text mining | PubMed |
| Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer. | Cells | 2022 | 35954292 | PubTator, text mining | PubMed |
| ENO2 Promotes Colorectal Cancer Metastasis by Interacting with the LncRNA CYTOR and Activating YAP1-Induced EMT. | Cells | 2022 | 35954207 | PubTator, text mining | PubMed |
| CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells. | Cancer Lett | 2022 | 35944750 | PubTator, text mining | PubMed |
| Piezo1 activation facilitates ovarian cancer metastasis via Hippo/YAP signaling axis. | Channels (Austin) | 2022 | 35942515 | PubTator, text mining | PubMed |
| Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner. | Cell Death Dis | 2022 | 35941108 | PubTator, text mining | PubMed |
| A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis. | Cancer Res Commun | 2022 | 35937460 | PubTator, text mining | PubMed |
| Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma. | Front Mol Neurosci | 2022 | 35935338 | PubTator, text mining | PubMed |
| The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression. | Front Oncol | 2022 | 35928868 | PubTator, text mining | PubMed |
| N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation. | Contrast Media Mol Imaging | 2022 | 35924072 | PubTator, text mining | PubMed |
| Irisin Ameliorates Intervertebral Disc Degeneration by Activating LATS/YAP/CTGF Signaling. | Oxid Med Cell Longev | 2022 | 35915608 | PubTator, text mining | PubMed |
| Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers. | Exp Dermatol | 2022 | 35913427 | PubTator, text mining | PubMed |
| Clinical potential of the Hippo-YAP pathway in bladder cancer. | Front Oncol | 2022 | 35912245 | PubTator, text mining | PubMed |
| The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends? | Front Mol Biosci | 2022 | 35911967 | PubTator, text mining | PubMed |
| Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP. | Target Oncol | 2022 | 35906513 | PubTator, text mining | PubMed |
| EGF Receptor Signaling Modulates YAP Activation and Promotes Experimental Proliferative Vitreoretinopathy. | Invest Ophthalmol Vis Sci | 2022 | 35895037 | PubTator, text mining | PubMed |
| Regulation of Life & Death by REGγ. | Cells | 2022 | 35892577 | PubTator, text mining | PubMed |
| Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I). | Int J Mol Sci | 2022 | 35887090 | PubTator, text mining | PubMed |
Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation Abilities of Small Cell Lung Cancer (SCLC) Cells. | Biomedicines | 2022 | 35885009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=37